zalcitabine has been researched along with Luft Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beauvoit, B; Bonnet, J; Deveaud, C; Kirschner, J; Lebrecht, D; Müller, K; Venhoff, AC; Venhoff, N; Walker, UA | 1 |
Beauvoit, B; Bonnet, J; Deveaud, C; Kirschner, J; Lebrecht, D; Walker, UA | 1 |
Dubowitz, V; Freeman-Emmerson, C; Hansen, FJ; Kidd, H; Morten, K; Potter, C; Poulton, J; Sewry, C; Stephenson, J; Whitehouse, W | 1 |
3 other study(ies) available for zalcitabine and Luft Disease
Article | Year |
---|---|
Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues.
Topics: Administration, Oral; Animals; Anti-HIV Agents; DNA, Mitochondrial; Drug Interactions; Lipid Peroxidation; Male; Mice; Mice, Inbred BALB C; Mitochondrial Encephalomyopathies; Mitochondrial Myopathies; Uridine; Zalcitabine; Zidovudine | 2010 |
Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.
Topics: Animals; DNA, Mitochondrial; Drug Interactions; Electron Transport; Electron Transport Complex IV; Gene Dosage; Lactates; Lipid Peroxidation; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Mitochondrial Myopathies; Muscle, Skeletal; Reverse Transcriptase Inhibitors; Triglycerides; Uridine; Zalcitabine; Zidovudine | 2008 |
Deficiency of the human mitochondrial transcription factor h-mtTFA in infantile mitochondrial myopathy is associated with mtDNA depletion.
Topics: Base Sequence; Cell Line; Cell Nucleus; Child, Preschool; Cytochrome-c Oxidase Deficiency; DNA; DNA Primers; DNA-Binding Proteins; DNA, Mitochondrial; Humans; Infant; Infant, Newborn; Male; Mitochondria, Muscle; Mitochondrial Myopathies; Mitochondrial Proteins; Molecular Sequence Data; Muscle, Skeletal; Nuclear Proteins; Polymerase Chain Reaction; Reference Values; Transcription Factors; Zalcitabine | 1994 |